{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T05:53:56Z","timestamp":1784440436563,"version":"3.55.0"},"reference-count":30,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["19K07942"],"award-info":[{"award-number":["19K07942"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2024,9,23]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To investigate the significance of regulatory T cells (Tregs) and programmed cell death 1 (PD-1)<jats:sup>+<\/jats:sup>cytotoxic T lymphocytes (CTLs) in the vitreous of patients with vitreoretinal lymphoma (VRL) and uveitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study involved 51 patients with VRL and uveitis, 15 males and 36 females (mean age: 72 years, range: 51\u201386 years), who underwent vitrectomy at the Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan, from December 2019 to February 2024. All patients underwent lymphocyte surface antigen analysis via flow cytometry, and the proportion of Tregs in CD4<jats:sup>+<\/jats:sup>T lymphocytes and PD-1<jats:sup>+<\/jats:sup>CTLs in CD8<jats:sup>+<\/jats:sup>T lymphocytes was measured.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This study involved B cell VRL (B-VRL, n=16), sarcoidosis (n=8), human herpesvirus (HHV)-associated uveitis (n=7), human T cell lymphotropic virus type 1 associated uveitis (HAU, n=3) and unclassifiable uveitis (n=17) cases. The median proportions of Tregs were significantly lower in B-VRL (2.2%) compared with sarcoidosis (8.5%), HHV-associated uveitis (16.4%) and unclassifiable uveitis (10.1%) (p&lt;0.05). Conversely, a significantly higher proportion of PD-1<jats:sup>+<\/jats:sup>CTLs was found in B-VRL (95.6%) compared with sarcoidosis (61.1%), HHV-associated uveitis (67.1%) and unclassifiable (64.8%) (p&lt;0.05). Receiver operating characteristic analysis of Tregs and PD-1<jats:sup>+<\/jats:sup>CTLs proportions in B-VRL revealed high area under the curve values of 0.913 and 0.940, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings indicate that analysis of the ratio of Tregs and PD-1<jats:sup>+<\/jats:sup>CTLs via flow cytometry is helpful in diagnosing B-VRL.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjo-2024-326240","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T17:20:15Z","timestamp":1728926415000},"page":"510-515","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Novel diagnostic method for B cell vitreoretinal lymphoma by identification of regulatory T cells and PD-1<sup>+<\/sup>cytotoxic T lymphocytes in the vitreous via flow cytometry"],"prefix":"10.1136","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9014-8046","authenticated-orcid":false,"given":"Hideto","family":"Deguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9955-9431","authenticated-orcid":false,"given":"Kenji","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1595-8524","authenticated-orcid":false,"given":"Tohru","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6536-9701","authenticated-orcid":false,"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"2025032402050696000_109.4.510.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2013.12.001"},{"key":"2025032402050696000_109.4.510.2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ajo.2013.11.002","article-title":"Neoplastic masquerade syndromes in patients with uveitis","volume":"157","author":"Grange","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"2025032402050696000_109.4.510.3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10384-020-00809-1","article-title":"Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey","volume":"65","author":"Sonoda","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"2025032402050696000_109.4.510.4","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-012-0150-7"},{"key":"2025032402050696000_109.4.510.5","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-315511"},{"key":"2025032402050696000_109.4.510.6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194546","article-title":"Update in Molecular Testing for Intraocular Lymphoma","volume":"14","author":"Heiferman","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025032402050696000_109.4.510.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.05.033"},{"key":"2025032402050696000_109.4.510.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2006.02348.x"},{"key":"2025032402050696000_109.4.510.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2007.01836.x"},{"key":"2025032402050696000_109.4.510.10","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.148"},{"key":"2025032402050696000_109.4.510.11","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001173","article-title":"Programmed Cell Death Protein 1-Positive CD8+ T Cells in Multiple Sclerosis: Exhausted Fighters or Peacekeepers","volume":"9","author":"Smolders","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025032402050696000_109.4.510.12","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862"},{"key":"2025032402050696000_109.4.510.13","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-012017-043208"},{"key":"2025032402050696000_109.4.510.14","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1080\/09273948.2021.1873394","article-title":"More Accurate Diagnosis of Vitreoretinal Lymphoma Using a Combination of Diagnostic Test Results: A Prospective Observational Study","volume":"30","author":"Tanaka","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"2025032402050696000_109.4.510.15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10384-023-00997-6","article-title":"Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives","volume":"67","author":"Kaburaki","year":"2023","journal-title":"Jpn J Ophthalmol"},{"key":"2025032402050696000_109.4.510.16","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313356"},{"key":"2025032402050696000_109.4.510.17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10384-020-00794-5","article-title":"Practical use of multiplex and broad-range PCR in ophthalmology","volume":"65","author":"Sugita","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"2025032402050696000_109.4.510.18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ophtha.2020.09.028","article-title":"Multiplex Solid-Phase Real-Time Polymerase Chain Reaction without DNA Extraction: A Rapid Intraoperative Diagnosis Using Microvolumes","volume":"128","author":"Nakano","year":"2021","journal-title":"Ophthalmology"},{"key":"2025032402050696000_109.4.510.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)73974-1"},{"key":"2025032402050696000_109.4.510.20","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00270"},{"key":"2025032402050696000_109.4.510.21","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.3390\/curroncol29100543","article-title":"Primary Vitreoretinal Lymphoma: Current Diagnostic Laboratory Tests and New Emerging Molecular Tools","volume":"29","author":"Melli","year":"2022","journal-title":"Curr Oncol"},{"key":"2025032402050696000_109.4.510.22","first-page":"93","article-title":"Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma","volume":"15","author":"Chan","year":"2013","journal-title":"Discov Med"},{"key":"2025032402050696000_109.4.510.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)72217-2"},{"key":"2025032402050696000_109.4.510.24","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.32"},{"key":"2025032402050696000_109.4.510.25","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6322"},{"key":"2025032402050696000_109.4.510.26","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1679197","article-title":"Immune Privilege and Eye-Derived T-Regulatory Cells","volume":"2018","author":"Keino","year":"2018","journal-title":"J Immunol Res"},{"key":"2025032402050696000_109.4.510.27","doi-asserted-by":"publisher","DOI":"10.1038\/nri2343"},{"key":"2025032402050696000_109.4.510.28","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2010.121"},{"key":"2025032402050696000_109.4.510.29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/bjh.18775","article-title":"Safety and efficacy of nivolumab in patients who failed to achieve a complete remission after CD19-directed CAR T-cell therapy in diffuse large B cell lymphoma","volume":"202","author":"Gazeau","year":"2023","journal-title":"Br J Haematol"},{"key":"2025032402050696000_109.4.510.30","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ophtha.2024.03.017","article-title":"Incident Noninfectious Uveitis Risk after Immune Checkpoint Inhibitor Treatment","volume":"131","author":"Chang","year":"2024","journal-title":"Ophthalmology"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2024-326240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T09:10:07Z","timestamp":1742807407000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2024-326240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,3,20]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1136\/bjo-2024-326240"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2024-326240","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]}}}